SLL Revenue and Competitors
Estimated Revenue & Valuation
- SLL's estimated annual revenue is currently $137.7M per year.
- SLL's estimated revenue per employee is $498,913
Employee Data
- SLL has 276 Employees.
- SLL grew their employee count by -18% last year.
SLL's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Director Information Technology | Reveal Email/Phone |
2 | Fitness Manager | Reveal Email/Phone |
3 | Operations Manager | Reveal Email/Phone |
4 | Multi Site General Manager | Reveal Email/Phone |
SLL Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $25.1M | 86 | 12% | N/A | N/A |
#2 | $35.6M | 110 | 1% | N/A | N/A |
#3 | $61.5M | 207 | 5% | N/A | N/A |
#4 | N/A | 0 | N/A | N/A | N/A |
#5 | $23M | 85 | -19% | £8.2M | N/A |
#6 | $7.1M | 33 | -8% | N/A | N/A |
#7 | $17.7M | 52 | -13% | N/A | N/A |
#8 | $150.5M | 446 | 9% | N/A | N/A |
#9 | $159.3M | 446 | 14% | N/A | N/A |
#10 | $122.9M | 364 | 6% | N/A | N/A |
What Is SLL?
Welcome to Stevenage Leisure Ltd. We are committed to improving the health and wellbeing of our local communities by delivering high quality and value for money leisure and cultural opportunities for all.\r\n\r\nWorking closely in partnership with 4 local authorities and the Knights Templar School, we are a registered charity, a non-profit distributing organisation managing 17 centres across 9 towns, with a dedicated team of over 1,000. Any surpluses generated through our operations are reinvested into the facilities for the benefit of our clients, staff, and most importantly the 3 million visitors to our centres every year.
keywords:N/A
N/A
Total Funding
276
Number of Employees
$137.7M
Revenue (est)
-18%
Employee Growth %
N/A
Valuation
N/A
Accelerator
SLL News
Ublituximab/Umbralisib Applications Voluntary Withdrawn for CLL and SLL Indications ... TG Therapeutics made the decision to voluntarily pull the...
The pending biologics license application (BLA)/supplemental new drug application (sNDA) for the combination of ublituximab (TG-1101) and...
Ukoniq Taken Off the Market; Pending Applications for CLL, SLL ... chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).
Other Companies in Stevenage
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $68.2M | 303 | 1% | N/A |
#2 | $43.7M | 313 | -17% | $276M |
#3 | $43.7M | 315 | -34% | $276M |
#4 | $134.1M | 330 | N/A | N/A |
#5 | $97.9M | 381 | 23% | N/A |